Sun, T.; Katenka, N.; Kogut, S.; Bratberg, J.; Rich, J.; Buchanan, A.
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology 2022, 1, 101-112.
https://doi.org/10.3390/pharma1030010
AMA Style
Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A.
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology. 2022; 1(3):101-112.
https://doi.org/10.3390/pharma1030010
Chicago/Turabian Style
Sun, Tianyu, Natallia Katenka, Stephen Kogut, Jeffrey Bratberg, Josiah Rich, and Ashley Buchanan.
2022. "Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States" Pharmacoepidemiology 1, no. 3: 101-112.
https://doi.org/10.3390/pharma1030010
APA Style
Sun, T., Katenka, N., Kogut, S., Bratberg, J., Rich, J., & Buchanan, A.
(2022). Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology, 1(3), 101-112.
https://doi.org/10.3390/pharma1030010